ATE424195T1 - Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen - Google Patents
Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzenInfo
- Publication number
- ATE424195T1 ATE424195T1 AT04734238T AT04734238T ATE424195T1 AT E424195 T1 ATE424195 T1 AT E424195T1 AT 04734238 T AT04734238 T AT 04734238T AT 04734238 T AT04734238 T AT 04734238T AT E424195 T1 ATE424195 T1 AT E424195T1
- Authority
- AT
- Austria
- Prior art keywords
- amino
- treatment
- medication
- production
- propanediol derivatives
- Prior art date
Links
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical class OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03012864A EP1484057A1 (de) | 2003-06-06 | 2003-06-06 | Verwendung von 2-amino-1,3-propandiolderivaten zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424195T1 true ATE424195T1 (de) | 2009-03-15 |
Family
ID=33155170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04734238T ATE424195T1 (de) | 2003-06-06 | 2004-05-21 | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP1484057A1 (de) |
| JP (1) | JP4778419B2 (de) |
| AT (1) | ATE424195T1 (de) |
| AU (1) | AU2004246763B2 (de) |
| BR (1) | BRPI0411208A (de) |
| CA (1) | CA2528409A1 (de) |
| DE (1) | DE602004019778D1 (de) |
| IL (1) | IL172290A (de) |
| MX (1) | MXPA05012797A (de) |
| WO (1) | WO2004110421A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101346527B1 (ko) * | 2005-12-15 | 2013-12-31 | 미쓰비시 타나베 파마 코퍼레이션 | 아민 화합물 및 그 의약 용도 |
| JP4587961B2 (ja) * | 2006-01-16 | 2010-11-24 | 独立行政法人科学技術振興機構 | 神経因性疼痛治療剤 |
| EP2177521A1 (de) | 2008-10-14 | 2010-04-21 | Almirall, S.A. | Neue 2-Amidothiadiazol-Derivate |
| EP2202232A1 (de) | 2008-12-26 | 2010-06-30 | Laboratorios Almirall, S.A. | 1,2,4 Oxadiazolderivate und ihr Einsatz als Arzneimittel |
| EP2210890A1 (de) | 2009-01-19 | 2010-07-28 | Almirall, S.A. | Oxadiazol Derivate als S1P1 Rezeptor Agonisten |
| EP2305660A1 (de) | 2009-09-25 | 2011-04-06 | Almirall, S.A. | Neue Thiadiazolderivate |
| EP2343287A1 (de) | 2009-12-10 | 2011-07-13 | Almirall, S.A. | Neue 2-Aminothiadiazol-Derivate |
| EP2366702A1 (de) | 2010-03-18 | 2011-09-21 | Almirall, S.A. | Neue Oxadiazolderivate |
| EP2390252A1 (de) | 2010-05-19 | 2011-11-30 | Almirall, S.A. | Neue Pyrazolderivate |
| WO2012015758A2 (en) * | 2010-07-30 | 2012-02-02 | Saint Louis University | Methods of treating pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2249653A1 (en) * | 1973-11-02 | 1975-05-30 | Sobio Lab | Stable acetyl salicyclic acid salts - having anti-inflammatory, anti-pyretic and analgesic props. |
| WO1994008943A1 (fr) * | 1992-10-21 | 1994-04-28 | Yoshitomi Pharmaceutical Industries, Ltd. | Compose 2-amino-1,3-propanediol et immunosuppresseur |
| HU224814B1 (en) * | 1995-12-28 | 2006-02-28 | Mitsubishi Pharma Corp | Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases |
| JPH11209277A (ja) * | 1998-01-19 | 1999-08-03 | Yoshitomi Pharmaceut Ind Ltd | 医薬組成物 |
| GB9624038D0 (en) * | 1996-11-19 | 1997-01-08 | Sandoz Ltd | Organic compounds |
| USRE39072E1 (en) * | 1997-04-04 | 2006-04-18 | Mitsubishi Pharma Corporation | 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| JP2001261575A (ja) * | 2000-03-13 | 2001-09-26 | General Hospital Corp | 血管収縮を調節する方法とその組成物 |
-
2003
- 2003-06-06 EP EP03012864A patent/EP1484057A1/de not_active Withdrawn
-
2004
- 2004-05-21 JP JP2006508187A patent/JP4778419B2/ja not_active Expired - Fee Related
- 2004-05-21 CA CA002528409A patent/CA2528409A1/en not_active Withdrawn
- 2004-05-21 AU AU2004246763A patent/AU2004246763B2/en not_active Ceased
- 2004-05-21 WO PCT/EP2004/005470 patent/WO2004110421A1/en not_active Ceased
- 2004-05-21 MX MXPA05012797A patent/MXPA05012797A/es active IP Right Grant
- 2004-05-21 DE DE602004019778T patent/DE602004019778D1/de not_active Expired - Lifetime
- 2004-05-21 EP EP04734238A patent/EP1635803B1/de not_active Expired - Lifetime
- 2004-05-21 BR BRPI0411208-3A patent/BRPI0411208A/pt not_active Application Discontinuation
- 2004-05-21 AT AT04734238T patent/ATE424195T1/de not_active IP Right Cessation
-
2005
- 2005-11-30 IL IL172290A patent/IL172290A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004110421A1 (en) | 2004-12-23 |
| JP2006527171A (ja) | 2006-11-30 |
| JP4778419B2 (ja) | 2011-09-21 |
| DE602004019778D1 (de) | 2009-04-16 |
| EP1484057A1 (de) | 2004-12-08 |
| IL172290A0 (en) | 2006-04-10 |
| AU2004246763A1 (en) | 2004-12-23 |
| AU2004246763B2 (en) | 2009-05-28 |
| MXPA05012797A (es) | 2006-05-17 |
| EP1635803B1 (de) | 2009-03-04 |
| CA2528409A1 (en) | 2004-12-23 |
| BRPI0411208A (pt) | 2006-07-18 |
| EP1635803A1 (de) | 2006-03-22 |
| IL172290A (en) | 2011-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200900136A1 (ru) | Пирролопиримидины для фармацевтических композиций | |
| DK1613304T3 (da) | DPP-IV-inhibitorer | |
| DE602004019198D1 (de) | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege | |
| TW200745070A (en) | Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use | |
| NO20053748L (no) | Pyrrolopyridazinderivater. | |
| ATE547417T1 (de) | Dihydropyrimidinverbindungen und ihre verwendungen bei der herstellung von medikamenten zur behandlung und prävention antiviraler krankheiten | |
| ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| NO20082096L (no) | Azaindol-2-karboksamidderivativer | |
| ATE548032T1 (de) | Verwendung von chlorguanabenzderivaten zur behandlung von mit polyglutaminexpansion assoziierten erkrankungen | |
| CY1109569T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης | |
| ATE424195T1 (de) | Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| WO2004087700A8 (fr) | Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur | |
| ATE445617T1 (de) | Chinolinderivat, dessen verwendung, herstellung und dieses enthaltendes arzneimittel | |
| ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
| ATE527997T1 (de) | Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien | |
| EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
| MA27649A1 (fr) | Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci. | |
| EA200401432A1 (ru) | Сложноэфирные производные декагидроизохинолин-3-карбоновой кислоты в качестве анальгетиков | |
| TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
| ATE369849T1 (de) | Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen | |
| ATE505193T1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| ATE345124T1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia | |
| ATE473737T1 (de) | Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |